We are live on
!
Find out more
PM
Penbrook Management Portfolio holdings
AUM
$169M
Turnover
8.49%
1-Year Est. Return
32.52%
This Fund
S&P 500
This Quarter
Est. Return
+24.85%
1 Year Est. Return
+32.52%
3 Year Est. Return
+106.62%
5 Year Est. Return
+155.24%
10 Year Est. Return
–
AUM
$157M
AUM Growth
+$24.7M
(+19%)
Cap. Flow
-$334K
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
45.13%
Holding
104
New
11
Increased
18
Reduced
23
Closed
3
Avg Time Held
5.6
years
Top 10 Avg Time Held
5.1
years
Top 20 Avg Time Held
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Allot
ALLT
|
+$2.05M |
| 2 |
Baytex Energy
BTE
|
+$1.84M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$473K |
| 4 |
SA
Seabridge Gold
SA
|
+$449K |
| 5 |
BioLife Solutions
BLFS
|
+$387K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aehr Test Systems
AEHR
|
+$6.79M |
| 2 |
Planet Labs
PL
|
+$889K |
| 3 |
Photronics
PLAB
|
+$325K |
| 4 |
ExxonMobil
XOM
|
+$217K |
| 5 |
Nike
NKE
|
+$209K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.86% |
| 2 | Healthcare | 17.25% |
| 3 | Communication Services | 15.32% |
| 4 | Energy | 10.09% |
| 5 | Consumer Discretionary | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Amplitude
AMPL
$1.84B
| $373K | 0.24% |
+48,705
| New | +$336K |
2026 Q2
0 quarters
|
|
77
Rithm Capital
RITM
$4.84B
| $368K | 0.23% |
+39,200
| New | +$374K |
2026 Q2
0 quarters
|
|
78
IBM
IBM
$219B
| $361K | 0.23% |
1,283
| – | – |
2022 Q1
17 quarters
|
|
79
Invesco S&P 500 Equal Weight ETF
RSP
$97.8B
| $355K | 0.23% |
1,670
| – | – |
2017 Q4
34 quarters
|
|
80
TETRA Technologies
TTI
$788M
| $298K | 0.19% |
26,260
-150
| -0.6% | -$1.47K |
2025 Q3
3 quarters
|
|
81
Teradyne
TER
$50.8B
| $290K | 0.19% |
+600
| New | +$226K |
2026 Q2
0 quarters
|
|
82
State Street SPDR Portfolio S&P 500 ETF
SPYM
$176B
| $270K | 0.17% |
3,075
-105
| -3% | -$8.96K |
2025 Q2
4 quarters
|
|
83
Iovance Biotherapeutics
IOVA
$6.17B
| $258K | 0.16% |
61,945
+19,500
| +46% | +$74.1K |
2025 Q4
2 quarters
|
|
84
Reaves Utility Income Fund
UTG
$3.23B
| $249K | 0.16% |
6,125
| – | – |
2023 Q2
12 quarters
|
|
85
John Wiley & Sons Class A
WLY
$2.67B
| $243K | 0.15% |
+5,000
| New | +$210K |
2026 Q2
0 quarters
|
|
86
JPMorgan Equity Premium Income ETF
JEPI
$45.8B
| $239K | 0.15% |
4,225
| – | – |
2023 Q4
10 quarters
|
|
87
Golub Capital BDC
GBDC
$3.15B
| $233K | 0.15% |
18,060
+3,380
| +23% | +$44K |
2024 Q4
6 quarters
|
|
88
Chevron
CVX
$441B
| $228K | 0.15% |
1,377
| – | – |
2025 Q3
3 quarters
|
|
89
Antero Midstream
AM
$9.8B
| $225K | 0.14% |
9,900
| – | – |
2026 Q1
1 quarter
|
|
90
Merck
MRK
$360B
| $218K | 0.14% |
1,700
| – | – |
2026 Q1
1 quarter
|
|
91
JPMorgan Chase
JPM
$902B
| $216K | 0.14% |
+660
| New | +$205K |
2026 Q2
0 quarters
|
|
92
ConocoPhillips
COP
$176B
| $211K | 0.13% |
2,025
| – | – |
2026 Q1
1 quarter
|
|
93
First American
FAF
$6.63B
| $206K | 0.13% |
+3,000
| New | +$200K |
2026 Q2
0 quarters
|
|
94
Invesco Municipal Trust
VKQ
$491M
| $201K | 0.13% |
20,000
| – | – |
2013 Q4
50 quarters
|
|
95
Sky Harbour Group
SKYH
$360M
| $192K | 0.12% |
+19,530
| New | +$191K |
2026 Q2
0 quarters
|
|
96
Barnes & Noble Education
BNED
$449M
| $188K | 0.12% |
+15,000
| New | +$157K |
2026 Q2
0 quarters
|
|
97
Nuveen Municipal Value Fund
NUV
$1.73B
| $184K | 0.12% |
20,000
| – | – |
2019 Q3
27 quarters
|
|
98
Aquestive Therapeutics
AQST
$474M
| $180K | 0.11% |
43,300
+17,735
| +69% | +$74.6K |
2025 Q1
5 quarters
|
|
99
Dynex Capital
DX
$2.71B
| $132K | 0.08% |
10,050
| – | – |
2026 Q1
1 quarter
|
|
100
Ondas Inc
ONDS
$3.52B
| $82.4K | 0.05% |
10,005
| – | – |
2025 Q2
4 quarters
|
|
Similar funds
ACA
CCM
CIA
EG
ANHIM
WS
CBOR
NWMG
Penbrook Management's Q2 2026 Portfolio in Review
As of Q2 2026, Penbrook Management held 104 positions worth $157M, up 19% from $132M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Penbrook Management's Q2 2026 filing shows 11 new, 18 increased, 23 reduced and 3 closed positions. Its largest new stake was Allot: 275,295 shares worth $2.44M. The largest sale was Aehr Test Systems, an estimated $6.79M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Communication Services.
- Penbrook Management's largest Q2 2026 buy was Allot: 275,295 shares worth $2.44M.
- Penbrook Management added most to Seabridge Gold in Q2 2026, an estimated $449K increase.
- Penbrook Management's biggest Q2 2026 reduction was Aehr Test Systems, cutting an estimated $6.79M.
- Penbrook Management fully exited ExxonMobil in Q2 2026, selling an estimated $217K.
- Penbrook Management's ten largest holdings make up 45% of its $157M portfolio in Q2 2026.
- Penbrook Management opened 11 new positions and closed 3 in Q2 2026.
- Penbrook Management's portfolio value rose 19% quarter-over-quarter to $157M.
Based on Penbrook Management's 13F filing for Q2 2026, filed 23 Jul 2026.